Kevin Du, MD, Radiation Oncology, New York, NY, NYU Langone Hospitals

KevinDuMD

Radiation Oncology New York, NY

Gastrointestinal Cancer

Associate Professor, Residency Program Director, Radiation Oncology, New York University School of Medicine

Dr. Du is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Du's full profile

Already have an account?

Education & Training

  • New York University
    New York UniversityOTHER_TRAINING
  • New York University School of MedicineOTHER_TRAINING
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemRESIDENCY
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemINTERNSHIP
  • University of Pennsylvania School of MedicineOTHER_TRAINING
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaMEDICAL_SCHOOL
  • California Institute of TechnologyOTHER_TRAINING

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2016 - 2019
  • NY State Medical License
    NY State Medical License 2011 - 2022
  • PA State Medical License
    PA State Medical License 2006 - 2014
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Educator of the Year Award Association of Residents in Radiation Oncology, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Prostate Brachytherapy Fellowship Recipient American Brachytherapy Society, 2010
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Safety and Efficacy of Combination Targeted Therapy and Radiotherapy  
    Bitterman DS, Du KL, Targeted Oncology, 1/9/2017
  • Radiation Therapy Induces Macrophages to Suppress Immune Responses Against Pancreatic Tumors in Mice  
    Seifert L, Werba G, Tiwari S, Ly NN, Nguy S, Alothman S, Alqunaibit D, Avanzi A, Daley D, Barilla R, Tippens D, Torres-Hernandez A, Hundeyin M, Mani V, Hajdu C, Pellic..., Gastroenterology, 1/2/2016
  • Human Immunodeficiency Virus Infection is Associated with Poor Outcomes in Anal Cancer Patients in the Highly Active Antiretroviral Therapy Era  
    Grew D, Bitterman D, Leichman CG, Leichman L, Cohen R, Sanfillipo NS, Moore H, Du KL, Diseases of the Colon & Rectum, 1/1/2015
  • Join now to see all

Books/Book Chapters

Lectures

  • Radiation Induces M2 Macrophage Suppression of T-cell Responses Against Pancreatic Tumors in Mice. 
    Hawaii, HI, 2016; Philadelphia, PA, 2017 - 1/1/2017
  • There's Plenty of Room at the Bottom 
    Orlando, FL - 1/1/2016
  • Proton Therapy 
    NYU Langone Medical Center, New York, NY - 1/1/2016
  • Join now to see all

Press Mentions

  • MR-Linac-Delivered Adaptive Radiation Therapy Promising in Pancreatic Cancer
    MR-Linac-Delivered Adaptive Radiation Therapy Promising in Pancreatic Cancer

Hospital Affiliations